These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8038299)

  • 1. Buspirone induced prolactin release in mania.
    Yatham LN
    Biol Psychiatry; 1994 Apr; 35(8):553-6. PubMed ID: 8038299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin and cortisol responses to fenfluramine challenge in mania.
    Yatham LN
    Biol Psychiatry; 1996 Feb; 39(4):285-8. PubMed ID: 8645775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
    Thakore JH; O'Keane V; Dinan TG
    Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin supersensitivity: the pathophysiologic basis of non-ulcer dyspepsia? A preliminary report of buspirone/prolactin responses.
    Dinan TG; Yatham LN; Barry S; Chua A; Keeling PW
    Scand J Gastroenterol; 1990 May; 25(5):541-4. PubMed ID: 2359983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central 5-HT receptor hypersensitivity in migraine without aura.
    Cassidy EM; Tomkins E; Dinan T; Hardiman O; O'Keane V
    Cephalalgia; 2003 Feb; 23(1):29-34. PubMed ID: 12534577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity?
    Condren RM; Dinan TG; Thakore JH
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):349-54. PubMed ID: 12126875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model.
    O'Mahony S; Chua AS; Quigley EM; Clarke G; Shanahan F; Keeling PW; Dinan TG
    Neurogastroenterol Motil; 2008 Jun; 20(6):680-8. PubMed ID: 18194152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?
    Dinan TG; Mahmud N; Rathore O; Thakore J; Scott LV; Carr E; Naesdal J; O'Morain CA; Keeling PW
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1613-8. PubMed ID: 11564001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prolactin response to buspirone in chronic fatigue syndrome.
    Sharpe M; Clements A; Hawton K; Young AH; Sargent P; Cowen PJ
    J Affect Disord; 1996 Nov; 41(1):71-6. PubMed ID: 8938208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of fenfluramine stimulation on prolactin plasma levels in lithium long-term-treated manic-depressive patients and healthy subjects.
    Mühlbauer HD
    Pharmacopsychiatry; 1984 Nov; 17(6):191-3. PubMed ID: 6514782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Int Clin Psychopharmacol; 1992; 7(1):45-9. PubMed ID: 1624756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal response to buspirone is not impaired in major depression.
    Navinés R; Gómez-Gil E; Martín-Santos R; de Osaba MJ; Escolar G; Gastó C
    Hum Psychopharmacol; 2007 Aug; 22(6):389-95. PubMed ID: 17563921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin response to buspirone was reduced in violent compared to nonviolent parolees.
    Cherek DR; Moeller FG; Khan-Dawood F; Swann A; Lane SD
    Psychopharmacology (Berl); 1999 Feb; 142(2):144-8. PubMed ID: 10102766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.
    Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V
    Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma prolactin and growth hormone levels in manic patients treated with pimozide.
    Cookson JC; Silverstone T; Rees L
    Br J Psychiatry; 1982 Mar; 140():274-9. PubMed ID: 7093595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lithium on prolactin responses to thyrotropin releasing hormone in patients with manic state.
    Tanimoto K; Maeda K; Yamaguchi N; Chihara K; Fujita T
    Psychopharmacology (Berl); 1981; 72(2):129-33. PubMed ID: 6782601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxiety.
    Tollefson GD; Godes M; Montague-Clouse J; Lancaster SP; Garvey MJ
    J Clin Psychopharmacol; 1989 Apr; 9(2):132-6. PubMed ID: 2723131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prolactin during lithium treatment.
    Lanng Nielsen J; Amdisen A; Darling S; Pedersen EB
    Neuropsychobiology; 1977; 3(1):30-4. PubMed ID: 895996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin response to buspirone challenge in the presence of dopaminergic blockade.
    Maskall DD; Zis AP; Lam RW; Clark CM; Kuan AJ
    Biol Psychiatry; 1995 Aug; 38(4):235-9. PubMed ID: 8547445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.